Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | UBE2M | P61081 | 2/20 | 0.40 |
| ▸ | DCUN1D1 | Q96GG9 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18609697 | 1.00 | TRPM8 (0.46) | TRPM8TRPV1ALDH1A1CYP2C9CYP1A2 | |
| SCHEMBL14959022 | 1.00 | TRPM8 (0.46) | TRPM8TRPV1ALDH1A1CYP2C9CYP1A2 | |
| SCHEMBL14959021 | 0.89 | ALDH1A1 (0.56) | ALDH1A1CYP2C9CYP1A2KMT2AGAA | |
| SCHEMBL14959038 | 0.88 | ALDH1A1 (0.45) | ALDH1A1CYP2C9CYP1A2LMNAGAA | |
| SCHEMBL18609476 | 0.88 | ALDH1A1 (0.45) | ALDH1A1CYP2C9CYP1A2LMNAGAA | |
| SCHEMBL12176203 | 0.87 | NPSR1 (0.44) | ALDH1A1CYP2C9CYP1A2KMT2AGAA | |
| SCHEMBL14960573 | 0.87 | ALDH1A1 (0.48) | ALDH1A1CYP2C9CYP1A2KMT2ALMNA | |
| SCHEMBL13060130 | 0.87 | ALDH1A1 (0.48) | ALDH1A1CYP2C9CYP1A2KMT2ALMNA | |
| SCHEMBL18532596 | 0.87 | ALDH1A1 (0.48) | ALDH1A1CYP2C9CYP1A2KMT2ALMNA | |
| SCHEMBL18532609 | 0.87 | TRPM8 (0.44) | TRPM8TRPV1ALDH1A1CYP2C9CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230102258-A1 | C5AR ANTAGONISTS | CHEMOCENTRYX, INC. | 2023-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230102258-A1 | C5AR ANTAGONISTS | C5AR1, C5AR2, C3AR1 | TRPM8 1347/4885TRPV1 830/4885ALDH1A1 2966/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.